Weight Loss Effect of Akkermansia Muciniphila in Obese Patients

NACompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

January 21, 2025

Primary Completion Date

February 28, 2025

Study Completion Date

June 16, 2025

Conditions
28≤BMI≤35Kg/m2
Interventions
DIETARY_SUPPLEMENT

Probiotic

The trial phase of the study will last 12 weeks and each subject will make 4 follow-up visits (day 0, week 4, week 8 and week 12).

DIETARY_SUPPLEMENT

Placebo

The trial phase of the study will last 12 weeks and each subject will make 4 follow-up visits (day 0, week 4, week 8 and week 12).

Trial Locations (1)

710032

The First Affiliated Hospital, the Air Force Medical University, Xi'an

All Listed Sponsors
lead

Wecare Probiotics Co., Ltd.

INDUSTRY

NCT06780007 - Weight Loss Effect of Akkermansia Muciniphila in Obese Patients | Biotech Hunter | Biotech Hunter